R&I colleagues welcomed James McLaughlin, Chief Executive for Cure Leukaemia, to MFT, as he ran 14 km across Manchester to raise funds for blood cancer research at Manchester Royal Infirmary (MRI).
A revolutionary ward-based genetic test which can prevent stroke related death has received a UKCA product mark, paving the way for its introduction to the NHS.
On #Red4Research Day, Diana Cherian, Senior Clinical Research Nurse in the Vaccine Team at the MRI, shares her long held passion for research and why her new role means so much to her.
In her blog, Emily Weaver-Holding, Senior Clinical Trials Coordinator, Trauma and Emergency Care at Manchester Royal Infirmary, celebrates Pride Month.
For International Clinical Trials Day, Salah Hassan, talks about living with arthritis; explains why participating in the TAPER study is important to him and encourages others to be part of research.
The world’s first participant in a new COVID-19 trial taking place at MFT, is part of research that may provide important protection for people with a weakened immune system.